Takushi Oga, Ph.D.
President HMT America
Dr. Oga has been with HMT for over 10 years and led research projects and product development in Japan for 7 years. Dr. Oga joined HMT America 4 years ago as a business development strategist. With experience in metabolic analysis and engineering, he leads HMT America's business development and new product strategy.
Alexander Buko, Ph.D.
Vice President, Business and Product Development
Dr. Buko brings with him over 30 years of pharmaceutical experience with the FDA, Abbott Labs, and most recently with Biogen, Idec where he held the position of Senior Director of Translational Medicine. Alex has successfully led large scale omics projects in neurology, immunology, and oncology. With extensive experience in protein and metabolite based profiling, Alex leads project management and development of HMT’s biomarker-based platforms.
Laura Shelton, Ph.D.
Manager, Scientific Project Development
Laura Shelton is a trained biochemist and has been with HMT for over 5 years. She has a background in cancer metabolism and has extended her knowledge into the more general area of metabolic disorders including diabetes and inborn errors of metabolism. With extensive experience in both in vitro and in vivo experimental design, Dr. Shelton aids in research planning and provides a biological and statistical context to the data.
Mark Zbinden, Ph.D.
Scientific Project Coordinator
Mark Zbinden is a biochemist and educator, and the newest member of HMT. While his thesis work was in molecular neuroscience, he has a diverse scientific background: from artificial bilayer networks to bacterial protein characterization to the impact of lipid maturation in yeast metabolism. Utilizing his passion for education, Dr. Zbinden connects with clients and aids in experimental design, troubleshooting, and data interpretation.